Triple
T5114894
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Memantine |
E115307
|
entity |
| Predicate | targets |
P860
|
FINISHED |
| Object |
NMDA receptor
The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
|
E494104
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NMDA receptor | Statement: [Memantine, targets, NMDA receptor]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NMDA receptor Context triple: [Memantine, targets, NMDA receptor]
-
A.
memantine
Memantine is a medication that helps manage symptoms of moderate to severe Alzheimer's disease by modulating glutamate activity in the brain.
-
B.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
-
C.
hippocampus
The hippocampus is a key brain structure involved in forming and retrieving memories, spatial navigation, and regulating emotional responses.
-
D.
CB2 receptor
The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
-
E.
Hodgkin–Huxley model
The Hodgkin–Huxley model is a mathematical description of how action potentials in neurons are initiated and propagated through voltage-gated ion channels in the cell membrane.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NMDA receptor Triple: [Memantine, targets, NMDA receptor]
Generated description
The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: NMDA receptor Target entity description: The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
-
A.
memantine
Memantine is a medication that helps manage symptoms of moderate to severe Alzheimer's disease by modulating glutamate activity in the brain.
-
B.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
-
C.
hippocampus
The hippocampus is a key brain structure involved in forming and retrieving memories, spatial navigation, and regulating emotional responses.
-
D.
CB2 receptor
The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
-
E.
Hodgkin–Huxley model
The Hodgkin–Huxley model is a mathematical description of how action potentials in neurons are initiated and propagated through voltage-gated ion channels in the cell membrane.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd4441d1648190a54a533895041987 |
completed | March 20, 2026, 12:57 p.m. |
| NER | Named-entity recognition | batch_69bd75ce6044819094166aebf0688665 |
completed | March 20, 2026, 4:29 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bebaadfaac8190aa0407196e5c4c20 |
completed | March 21, 2026, 3:35 p.m. |
| NEDg | Description generation | batch_69bebb1a4370819085bcbe73a0b8c68e |
completed | March 21, 2026, 3:36 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69bebcf63784819097be14bb7dcbf4d9 |
completed | March 21, 2026, 3:44 p.m. |
Created at: March 20, 2026, 1:41 p.m.